Search

Your search keyword '"EHMT2"' showing total 98 results

Search Constraints

Start Over You searched for: Descriptor "EHMT2" Remove constraint Descriptor: "EHMT2" Search Limiters Academic (Peer-Reviewed) Journals Remove constraint Search Limiters: Academic (Peer-Reviewed) Journals
98 results on '"EHMT2"'

Search Results

1. Epigenetic alterations of TP53INP1 by EHMT2 regulate the cell cycle in gastric cancer

2. G9a in Cancer: Mechanisms, Therapeutic Advancements, and Clinical Implications.

3. EHMT2-mediated transcriptional reprogramming drives neuroendocrine transformation in non-small cell lung cancer.

4. EHMT2 promotes tumorigenesis in GNAQ/11-mutant uveal melanoma via ARHGAP29-mediated RhoA pathway

5. Galectin-7 Induction by EHMT2 Inhibition Enhances Immunity in Microsatellite Stability Colorectal Cancer.

6. EHMT2 promotes tumorigenesis in GNAQ/11-mutant uveal melanoma via ARHGAP29-mediated RhoA pathway.

7. Inhibition of the Tumor Suppressor Gene SPINK5 via EHMT2 Induces the Oral Squamous Cell Carcinoma Development.

9. G9a in Cancer: Mechanisms, Therapeutic Advancements, and Clinical Implications

10. Euchromatic histone lysine methyltransferase 2 facilitates radioresistance in prostate cancer by repressing endoplasmic reticulum protein 29 transcription

11. Euchromatic histone lysine methyltransferase 2 facilitates radioresistance in prostate cancer by repressing endoplasmic reticulum protein 29 transcription.

12. Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines.

13. De novo methylation of histone H3K23 by the methyltransferases EHMT1/GLP and EHMT2/G9a

14. EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression

15. An EHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer

16. G9a/EHMT2 is a Potential Prognostic Biomarker and Molecular Target in SHH Medulloblastoma.

17. De novo methylation of histone H3K23 by the methyltransferases EHMT1/GLP and EHMT2/G9a.

18. Targeting euchromatic histone lysine methyltransferases sensitizes colorectal cancer to histone deacetylase inhibitors.

19. MicroRNA-205-5p plays a suppressive role in the high-fat diet-induced atrial fibrosis through regulation of the EHMT2/IGFBP3 axis.

20. EHMT2 promotes the pathogenesis of hepatocellular carcinoma by epigenetically silencing APC expression

21. Negative regulation of CDKN1A by the histone methyltransferase EHMT2 for cell growth in colorectal cancer

22. EHMT2 methyltransferase governs cell identity in the lung and is required for KRAS G12D tumor development and propagation

23. Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines

24. An EHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer.

26. EHMT2 promotes the pathogenesis of hepatocellular carcinoma by epigenetically silencing APC expression.

27. Downregulation of a Dorsal Root Ganglion‐Specifically Enriched Long Noncoding RNA is Required for Neuropathic Pain by Negatively Regulating RALY‐Triggered Ehmt2 Expression.

28. EZH2/EHMT2 Histone Methyltransferases Inhibit the Transcription of DLX5 and Promote the Transformation of Myelodysplastic Syndrome to Acute Myeloid Leukemia

29. Downregulation of a Dorsal Root Ganglion‐Specifically Enriched Long Noncoding RNA is Required for Neuropathic Pain by Negatively Regulating RALY‐Triggered Ehmt2 Expression

30. Lysine methyltransferase G9a is an important modulator of trained immunity

31. Lysine methyltransferase G9a is an important modulator of trained immunity.

32. EHMT2/G9a as an Epigenetic Target in Pediatric and Adult Brain Tumors

33. Structure, Activity, and Function of the Protein Lysine Methyltransferase G9a

34. Towards the understanding of the activity of G9a inhibitors: an activity landscape and molecular modeling approach.

35. RNA-seq based transcriptome analysis of EHMT2 functions in breast cancer.

36. Inhibition of Euchromatic Histone Lysine Methyltransferase 2 (EHMT2) Suppresses the Proliferation and Invasion of Cervical Cancer Cells.

37. Age-associated H3K9me2 loss alters the regenerative equilibrium between murine lung alveolar and bronchiolar progenitors.

38. EHMT2 promotes the development of prostate cancer by inhibiting PI3K/AKT/mTOR pathway.

39. Novel SAR for quinazoline inhibitors of EHMT1 and EHMT2.

40. EHMT2 and SETDB1 protect the maternal pronucleus from 5mC oxidation.

41. Histone methyl transferases: A class of epigenetic opportunities to counter uncontrolled cell proliferation.

42. EHMT2 Inhibition Induces Cell Death in Human Non-Small Cell Lung Cancer by Altering the Cholesterol Biosynthesis Pathway

43. The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck.

44. EHMT2 is a metastasis regulator in breast cancer.

45. G9a controls placental vascular maturation by activating the Notch Pathway.

46. Novel benzothiazine-piperazine derivatives by peptide-coupling as potential anti-proliferative agents.

47. Association analysis between pseudorabies antibody and five single-nucleotide polymorphisms in pigs

48. PALI1 promotes tumor growth through competitive recruitment of PRC2 to G9A-target chromatin for dual epigenetic silencing.

49. S-adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3.

50. The lysine methyltransferase Ehmt2/G9a is dispensable for skeletal muscle development and regeneration.

Catalog

Books, media, physical & digital resources